Regulus Therapeutics (RGLS) Stock Chart & Stock Price History → The #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique Way (From Smallcaps Daily) (Ad) Free RGLS Stock Alerts $2.02 -0.06 (-2.88%) (As of 05/15/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Regulus Therapeutics Stock Price Performance5 Day Performance-8.60%1 Month Performance-21.09%3 Month Performance+32.03%6 Month Performance+48.53%Year-To-Date Performance+57.81%1 Year Performance+39.31% Receive RGLS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Regulus Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Manward PressThe most important AI company you've never heard ofBecause this small company solves the BIGGEST problem with Nvidia's AI chips. Already, Amazon, Microsoft, Google and others are lining up to get this company's products.Get the full story on this secret AI company poised for massive growth RGLS Stock Chart for Thursday, May, 16, 2024 RGLS Chart by TradingView Regulus Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/15/2024$2.08$2.02-2.88%$2.13$1.94605,591 shs$132.25 million05/14/2024$2.09$2.08-0.48%$2.17$2.01568,184 shs$136.18 million05/13/2024$2.21$2.09-5.43%$2.28$2.03543,653 shs$136.83 million05/10/2024$2.25$2.21-1.78%$2.33$2.13659,033 shs$144.67 million05/09/2024$2.27$2.25-0.88%$2.36$2.20612,282 shs$147.29 million05/08/2024$2.23$2.27+1.79%$2.32$2.16446,129 shs$148.59 million Get the Latest News and Ratings for RGLS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Regulus Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/07/2024$2.43$2.23-8.23%$2.49$2.18704,742 shs$145.98 million05/06/2024$2.65$2.43-8.30%$2.79$2.40891,188 shs$159.07 million05/03/2024$2.69$2.65-1.49%$2.83$2.64403,916 shs$173.47 million05/02/2024$2.51$2.69+7.17%$2.90$2.49709,956 shs$176.09 million05/01/2024$2.30$2.51+9.13%$2.67$2.21562,862 shs$164.31 million04/30/2024$2.52$2.30-8.73%$2.59$2.30234,543 shs$150.56 million04/29/2024$2.42$2.52+4.13%$2.60$2.41214,214 shs$164.96 million04/26/2024$2.27$2.42+6.61%$2.48$2.27204,765 shs$158.41 million04/25/2024$2.22$2.27+2.25%$2.29$2.1797,798 shs$148.59 million04/24/2024$2.26$2.22-1.77%$2.29$2.2291,807 shs$145.32 million04/23/2024$2.20$2.26+2.73%$2.34$2.14101,567 shs$147.94 million04/22/2024$2.13$2.20+3.29%$2.26$2.09127,028 shs$144.01 million04/19/2024$2.22$2.13-4.05%$2.31$2.09222,749 shs$139.43 million04/18/2024$2.34$2.22-5.13%$2.38$2.18202,895 shs$145.33 million04/17/2024$2.56$2.34-8.59%$2.60$2.33293,502 shs$153.18 million04/16/2024$2.78$2.56-7.91%$2.78$2.54455,033 shs$167.58 million04/15/2024$2.80$2.78-0.71%$2.83$2.66315,039 shs$181.98 million04/12/2024$2.78$2.80+0.72%$2.88$2.70343,835 shs$183.29 million04/11/2024$2.62$2.78+6.11%$2.86$2.62373,303 shs$181.98 million04/10/2024$2.70$2.62-2.96%$2.68$2.56192,165 shs$171.51 million04/09/2024$2.67$2.70+1.12%$2.77$2.61220,855 shs$176.74 million04/08/2024$2.54$2.67+5.12%$2.76$2.51348,161 shs$174.79 million04/05/2024$2.52$2.54+0.79%$2.67$2.45355,733 shs$166.27 million04/04/2024$2.61$2.52-3.45%$2.73$2.51266,130 shs$164.97 million04/03/2024$2.72$2.61-4.04%$2.79$2.60248,138 shs$170.85 million04/02/2024$2.80$2.72-2.86%$2.81$2.52826,404 shs$178.05 million04/01/2024$2.88$2.80-2.78%$2.91$2.59912,653 shs$183.29 million03/29/2024$2.88$2.88$2.93$2.80808,984 shs$58.24 million03/28/2024$2.88$2.88$2.92$2.80808,981 shs$58.23 million03/27/2024$2.85$2.88+1.23%$3.00$2.73886,367 shs$58.23 million03/26/2024$2.82$2.85+0.89%$3.00$2.67832,521 shs$57.53 million03/25/2024$2.69$2.82+5.03%$2.99$2.671.07 million shs$57.02 million03/22/2024$2.78$2.68-3.60%$2.84$2.56697,156 shs$54.19 million03/21/2024$2.50$2.78+11.20%$2.82$2.501.43 million shs$56.21 millionA ‘DeFi Summer’ Projected! (Ad)Top analysts are predicting DeFi coins to see massive gains in the coming months… During this dubbed ‘DeFi Summer…’ A coin that has been called the “DeFi pioneer” is poised to shoot up 3-7x!Just click here to learn how you can access this coin right now.03/20/2024$2.39$2.50+4.82%$2.52$2.20705,754 shs$50.55 million03/19/2024$2.36$2.39+1.06%$2.45$2.13685,551 shs$48.23 million03/18/2024$2.11$2.36+11.85%$2.41$2.03863,145 shs$47.72 million03/15/2024$2.45$2.11-13.70%$2.47$1.981.48 million shs$42.66 million03/14/2024$2.43$2.45+0.62%$2.64$1.902.41 million shs$49.45 million03/13/2024$2.36$2.43+2.97%$2.80$2.255.82 million shs$49.14 million03/12/2024$1.38$2.36+71.01%$3.79$1.98167.75 million shs$47.72 million03/11/2024$1.39$1.38-0.72%$1.43$1.3269,514 shs$27.90 million03/08/2024$1.42$1.39-2.11%$1.42$1.3518,980 shs$28.11 million03/07/2024$1.50$1.42-5.33%$1.52$1.3473,144 shs$28.71 million03/06/2024$1.48$1.50+1.35%$1.52$1.4712,848 shs$30.33 million03/05/2024$1.49$1.48-0.67%$1.54$1.4531,318 shs$29.93 million03/04/2024$1.49$1.49$1.57$1.4915,058 shs$30.13 million03/01/2024$1.47$1.49+1.36%$1.51$1.4517,956 shs$30.13 million02/29/2024$1.49$1.47-1.34%$1.54$1.4712,468 shs$29.72 million02/28/2024$1.51$1.49-1.00%$1.55$1.4927,527 shs$30.13 million02/27/2024$1.42$1.51+5.99%$1.55$1.40228,869 shs$30.43 million02/26/2024$1.46$1.42-2.74%$1.51$1.4211,188 shs$28.71 million02/23/2024$1.53$1.46-4.58%$1.54$1.4430,872 shs$29.52 million02/22/2024$1.51$1.53+1.32%$1.59$1.41136,987 shs$30.94 million02/21/2024$1.55$1.51-2.27%$1.57$1.5015,267 shs$30.53 million02/20/2024$1.53$1.55+0.98%$1.57$1.5046,599 shs$31.24 million02/19/2024$1.53$1.53$1.56$1.4954,600 shs$30.94 million02/16/2024$1.48$1.53+3.38%$1.56$1.4954,645 shs$30.94 million02/15/2024$1.48$1.48$1.54$1.4523,777 shs$29.93 million Related Companies: Alimera Sciences Stock Price Chart Rigel Pharmaceuticals Stock Price Chart Merrimack Pharmaceuticals Stock Price Chart Emergent BioSolutions Stock Price Chart Bolt Biotherapeutics Stock Price Chart XOMA Stock Price Chart Verastem Stock Price Chart Vanda Pharmaceuticals Stock Price Chart Lexicon Pharmaceuticals Stock Price Chart InterCure Stock Price Chart Receive RGLS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Regulus Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:RGLS) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyWATCH: The Truth About InflationBirch GoldHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldTop 5 AI Stocks to Buy for 2024Market Moving TrendsThis unknown company solves the biggest issue with AIManward PressTrump’s “Tax Free” Retirement Strategy Gold Safe Exchange Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Regulus Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.